Trial
NCT03224182
A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT)
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Spectrum Pharmaceuticals, Inc
Collaborators
—
Condition
Bladder Cancer
Intervention
Qapzola
Why stopped
Suspended development
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-28